CNBC’s Jim Cramer on Wednesday reviewed ten stocks worth more than $1 billion that have run up big this year, including Cava, ...

CNBC’s Jim Cramer suggested that if Trump’s new tax plans are similar to those he implemented in 2016, wealthy people will ...

We recently compiled a list of the Jim Cramer Talked About These 16 Stocks. In this article, we are going to take a look at ...

We recently compiled a list of the Jim Cramer Talked About These 16 Stocks. In this article, we are going to take a look at ...

Jim Cramer: This Financial Stock Is A Buy, Likes Broadcom Broadcom expanded its multi-year partnership with Telia Company to advance telecom and cloud infrastructure using VMware's product portfolio.

Analysts expect the Cambridge, Massachusetts-based company to report a quarterly loss at $1.9 per share, versus a year-ago loss of $9.53 per share. Moderna projects to report revenue of $1.25 billion ...

© 2024 The Arena Media Brands, LLC THESTREET is a registered trademark of TheStreet, Inc.

Moderna Inc. delivered better-than-expected profit and sales in the third quarter after an early start to sales of this season’s Covid boosters. The company’s latest Covid shot was approved ...

Shares up nearly 5% to $54.22 in early trading Spikevax COVID vaccine sales reached $1.8 billion, beating expectations Moderna expects lower COVID vaccine sales this year compared to 2023 $10 ...

Moderna on Thursday posted a surprise profit for the third quarter, smashing Wall Street estimates, as its cost-cutting efforts took hold and sales of its Covid vaccine came in higher than ...

Investing.com - Moderna (NASDAQ:MRNA) has reported a surprise net income in the third quarter and announced changes at its leadership team, as the drugmaker looks to address issues stemming from ...

(RTTNews) - Drug maker Moderna, Inc. (MRNA) reported Thursday that its third-quarter net income was $13 million, compared to a net loss of $3.63 billion a year ago. Earnings per share were $0.03 ...